lunes, 27 de enero de 2025

Akero drug reverses liver scarring in study of severe MASH patients Patients with cirrhosis due to MASH have a severe form of the disease with few treatment options outside of a liver transplant

https://www.statnews.com/2025/01/27/akero-efruxifermin-liver-fibrosis-mash/

No hay comentarios:

Publicar un comentario